Results

Total Results: 76 records

Showing results for "venous thromboembolism".
Users also searched for: vte

  1. www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
    May 09, 2005 - Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair evidence), dementia … Other harms include increased risk for breast cancer (good evidence), venous thromboembolism (good evidence … For example, for combined estrogen and progestin, some risks (such as the risks for venous thromboembolism … The estrogen-only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism .
  2. www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
    May 09, 2005 - Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair evidence), dementia … Other harms include increased risk for breast cancer (good evidence), venous thromboembolism (good evidence … For example, for combined estrogen and progestin, some risks (such as the risks for venous thromboembolism … The estrogen-only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism .
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
    May 01, 2005 - Other harms include increased risk for breast cancer (good evidence), venous thromboembolism (good evidence … Harms include increased risk for venous thromboembolism (fair evidence), stroke (fair evidence), dementia … The estrogen-only arm of the WHI trial showed a trend toward increased risk for venous thromboembolism … Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and … Hormone Replacement Therapy and Risk of Venous Thromboembolism.
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
    October 01, 2002 - Potential benefits of Hormone Replacement Therapy Analytic Framework 1 Venous thromboembolism (DVT/PE … Venous thromboembolism (deep vein thrombosis and pulmonary embolism)? 2. Breast cancer incidence? … Venous thromboembolism? … Hormone Replacement Therapy and Risk of Venous Thromboembolism. … Risk of venous thromboembolism in users of hormone replacement therapy.
  5. www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
    July 08, 2002 - incidence between the tamoxifen and placebo groups in this age group. 7 The relative risk increase in venousthromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - incidence between the tamoxifen and placebo groups in this age group. 7 The relative risk increase in venousthromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism
  7. www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
    August 21, 2002 - Although our review supports an association between HRT and increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone replacement therapy and risk of venous thromboembolism: a systematic review and meta-analysis … Risk of venous thromboembolism in users of hormone replacement therapy. … Venous thromboembolism?
  8. www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
    August 21, 2002 - Although our review supports an association between HRT and increased risk for venous thromboembolism … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone replacement therapy and risk of venous thromboembolism: a systematic review and meta-analysis … Risk of venous thromboembolism in users of hormone replacement therapy. … Venous thromboembolism?
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
    July 02, 2002 - incidence between the tamoxifen and placebo groups in this age group.7 The relative risk increase in venousthromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary36/menopausal-hormone-therapy-preventive-medication-2012
    May 29, 2012 - Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism … Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
    July 01, 2012 - Potential harms include coronary heart disease events; stroke; cognitive decline; venous thromboembolism
  12. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
    December 12, 2017 - thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI … thromboembolism (21 more cases [95% CI, 12 to 33]). … thromboembolism ( Table 3 and Figure 3 ; Table 4 summarizes the strength of evidence). … thromboembolism (21 more cases per 10,000 patient-years [95% CI, 12 to 33]) were also statistically … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
  13. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - thromboembolism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI … thromboembolism (21 more cases [95% CI, 12 to 33]). … thromboembolism ( Table 3 and Figure 3 ; Table 4 summarizes the strength of evidence). … thromboembolism (21 more cases per 10,000 patient-years [95% CI, 12 to 33]) were also statistically … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
  14. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
    April 19, 2022 - progestin is associated with moderate harms, including increased risk of invasive breast cancer, stroke, venousthromboembolism, dementia, gallbladder disease, and urinary incontinence.  … evidence that use of estrogen alone is associated with moderate harms, including increased risk of stroke, venousthromboembolism, gallbladder disease, and urinary incontinence.
  15. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/hypertensive-disorders-pregnancy-screening
    May 20, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venousthromboembolism (deep vein thrombosis/pulmonary embolism) Disseminated intravascular coagulation
  16. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
    September 02, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venousthromboembolism (deep vein thrombosis/pulmonary embolism) Disseminated intravascular coagulation
  17. www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - thromboembolism, and a small to moderate harm of increased risk of coronary heart disease. … thromboembolism. … thromboembolism between women randomized to hormone therapy vs placebo over 2 to 3 years; however, the … thromboembolism b 21 (12 to 33) Urinary incontinence 876 (606 to 1168) Benefits … thromboembolism b 11 (3 to 22) Urinary incontinence 1261 (880 to 1689) Benefits
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
    October 22, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions October 22, 2015 Recommendations made by the USPSTF are indepen…
  19. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - thromboembolism over 7.2 years (258 vs 181 cases; 77 more [95% CI, 19-153]), and urinary incontinence … thromboembolism (246 vs 126 cases; 120 more [95% CI, 68-185]) over 5.6 years; probable dementia (179 … thromboembolism ( Figure 3 ; strength of evidence reported in Table 2 ). … thromboembolism compared with those who received placebo (77 more cases per 10,000 persons over 7.2 … Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the
  20. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
    September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venousthromboembolism events) * Only tamoxifen is approved for use in premenopausal women. ** Aromatase inhibitors

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: